Bafna Pharmaceuticals Limited — Others, 14-08-2025: Copy of Newspaper Publication

Bafna Pharmaceuticals has released its financial results for the quarter ended June 30, 2025. The company reported a total income from operations of Rs. 34.62 Cr, with a net profit after tax of Rs. 3.39 Cr. This marks a significant turnaround compared to the loss of Rs. 0.72 Cr in the same quarter last year, reflecting improved profitability. Earnings per share stood at Rs. 1.43 for the quarter, up from Rs. 0.55 in the previous quarter and a loss of Rs. 0.31 last year. These results highlight a positive shift in the company's financial performance.